How to Get CagriSema Online in Charleroi

Many individuals in Charleroi are searching for advanced weight-loss solutions like CagriSema online. However, it's important to understand that CagriSema is currently not approved for weight-loss prescription in the EU and Hi-Doctor does not offer it. This innovative peptide combination is still undergoing clinical trials. Here's what CagriSema actually is, why it isn't readily available, and what proven, EU-approved weight-loss treatments you CAN get today from an EU-licensed doctor.

What is CagriSema, and why isn't it a normal option yet?

CagriSema is an investigational drug combining two active compounds: semaglutide (a GLP-1 receptor agonist) and cagrilintide (an amylin analogue). This unique combination aims to provide enhanced weight loss by targeting multiple pathways involved in appetite regulation and metabolism. Clinical trials are currently evaluating its efficacy and safety. The European Medicines Agency (EMA) has not yet granted marketing authorization for CagriSema, meaning it is not legally available for prescription in Belgium or any other EU country. Due to its experimental status, any online source offering CagriSema outside of official clinical trials is unregulated and poses significant health risks from potentially counterfeit or unsafe products.

Proven weight-loss medications available online today

While CagriSema is not yet an option, several effective and EU-approved medications are available for weight management, prescribed by EU-licensed doctors based on your individual health profile:

• Ozempic (semaglutide): An injectable GLP-1 receptor agonist, suitable for individuals with type 2 diabetes and obesity, often prescribed off-label for weight management where appropriate.
• Wegovy (semaglutide): A higher-dose injectable GLP-1 receptor agonist specifically approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.
• Mounjaro (tirzepatide): An injectable GIP and GLP-1 receptor agonist, approved for type 2 diabetes with significant weight loss benefits, and also being evaluated for direct weight management indications.
• Saxenda (liraglutide): An injectable GLP-1 receptor agonist, approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity.

How to get a weight-loss prescription online in Charleroi, Belgium

Hi-Doctor provides a convenient and safe pathway to access EU-approved weight-loss medications, reviewed by EU-licensed doctors. Here’s how it works:

1. Complete an online questionnaire: Spend 2–3 minutes filling out a detailed medical questionnaire about your health and weight history.
2. EU-licensed doctor reviews your case: An EU-licensed doctor thoroughly reviews your information to determine if a weight-loss treatment is medically appropriate for you.
3. REMPE prescription in <24 h if approved: If the doctor approves, you'll receive a REMPE electronic prescription (a Spanish standard valid EU-wide) within 24 hours. If treatment is not appropriate, your €25 consultation fee is automatically refunded.
4. Pick up at any EU pharmacy: Your prescription is delivered as a downloadable PDF to your private account and email. You can then print it or show it on your phone at any pharmacy in any EU country, including those in Charleroi, thanks to cross-border prescription directive 2011/24/EU.

The online consultation fee is a flat 25 €.

Why choose Hi-Doctor over unregulated peptide sellers

When considering weight-loss treatments, safety and efficacy are paramount. Hi-Doctor offers a secure, regulated, and medically sound alternative to risky grey-market peptide vendors:

• EU-Licensed Doctors: All consultations and prescriptions are handled by qualified, EU-licensed medical professionals.
• Real Medications: You receive prescriptions for genuine, EU-approved medications from legitimate pharmacies.
• Regulated & Traceable: Our platform ensures auditable, RGPD-compliant chat and medical records, providing transparency and patient protection.
• Proven Trust: With over 50,000 patients served and a 4.8-star rating on Trustpilot, Hi-Doctor is a trusted name in online healthcare.
• No Risk: If a doctor determines treatment isn't suitable, your 25€ consultation fee is refunded.

Contrast this with 'research chemicals' or unregulated online sellers who operate without medical oversight, offering products with unknown purity, dosage, and safety profiles.

Frequently asked questions

Is Cagrisema legal to buy online in Spain?

No, Cagrisema is not legally approved for commercial sale or prescription in Spain or any other EU country. Its sale outside of clinical trials is unregulated and potentially dangerous.

When will Cagrisema be available by prescription?

The timeline for Cagrisema's availability by prescription in the EU depends on the successful completion of clinical trials and subsequent approval by the European Medicines Agency (EMA). This process typically takes several years.

What's the closest approved alternative to Cagrisema?

While no direct equivalent exists, medications like Wegovy (semaglutide) and Mounjaro (tirzepatide) are currently the closest EU-approved alternatives, offering significant weight loss through similar or complementary mechanisms.

How much does an online weight-loss consultation cost?

An online weight-loss consultation with an EU-licensed doctor through Hi-Doctor costs a flat fee of 25 €. This fee is refunded if the doctor determines treatment is not appropriate for you.

Can I use a Hi-Doctor prescription at any pharmacy?

Yes, Hi-Doctor provides REMPE electronic prescriptions that are valid at any pharmacy in any EU country, including those in Charleroi, under the EU's cross-border prescription directive 2011/24/EU.

Is Hi-Doctor continuously onboarding new specialists?

Yes, Hi-Doctor is continuously onboarding new EU-licensed specialists across various conditions. If a specific treatment isn't covered today, patients can register their interest at hi-doctor.ai to be notified when a doctor becomes available.